Cargando…
Successful Treatment of Granulomatous Rosacea by JAK Inhibitor Abrocitinib: A Case Report
Granulomatous rosacea (GR) is a rare inflammatory skin disease characterized by persistent, hard, yellow, brown, red, or flesh-colored papules, plaques, or nodules on the face. Limited data are available on patients treated for GR, with only case reports and case series published. Herein, we describ...
Autores principales: | Ren, Mingyang, Yang, Xianhong, Teng, Yan, Lu, Wei, Ding, Yang, Tao, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674708/ https://www.ncbi.nlm.nih.gov/pubmed/38021428 http://dx.doi.org/10.2147/CCID.S440138 |
Ejemplares similares
-
A Case of Perioral Dermatitis Successfully Treated with Abrocitinib
por: Teng, Yan, et al.
Publicado: (2023) -
JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series
por: Xu, Bingyang, et al.
Publicado: (2023) -
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023) -
Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report
por: Teng, Yan, et al.
Publicado: (2023) -
Granulomatous rosacea: a case report
por: Kelati, A., et al.
Publicado: (2017)